VentriPoint Diagnostics

VentriPoint Diagnostics Gross Margin

The Gross Margin of VentriPoint Diagnostics (VPT.V) as of Oct 30, 2026 is 100.00 %. In the previous year, Gross Margin was 100.00 % — a change of 0.00% (lower).

Gross Margin

100.00 %

YoY

0.00%

Last updated:

Gross Margin of VentriPoint Diagnostics is 2025 100.00 % . Gross Margin of VentriPoint Diagnostics was 2024 100.00 % . It decreases by 0.00% lower compared to the previous year.

VentriPoint Diagnostics's gross margin stands at 100.0%, up from 72.9% several years earlier.

The VentriPoint Diagnostics Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2017
-2.82 CAD
Jan 1, 2018
43.53 CAD
Jan 1, 2019
45.88 CAD
Jan 1, 2020
72.94 CAD
Jan 1, 2022
84.80 CAD
Jan 1, 2023
-49.27 CAD
Jan 1, 2024
100.00 CAD
Jan 1, 2025
100.00 CAD
The VentriPoint Diagnostics Gross Margin history
YEARGross MarginYoY
100.00 %0.00%
100.00 %-302.96%
-49.27 %-158.10%
84.80 %+16.27%
72.94 %+58.99%
45.88 %+5.38%
43.53 %-1,645.37%
-2.82 %-78.65%
-13.19 %-45.89%
-24.38 %-220.17%
20.29 %-5,584.48%
-0.37 %-149.75%
0.74 %+5.60%
0.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VentriPoint Diagnostics Stock analysis

What does VentriPoint Diagnostics do? VentriPoint Diagnostics Ltd. develops and commercializes diagnostic tools for heart disease monitoring, focusing on the VentriPoint Medical System (VMS+). The VMS+ uses proprietary Knowledge Based Reconstruction (KBR) technology to create 3D heart models from ultrasound, providing volume and ejection fraction measurements comparable to MRI without requiring MRI scans. The company targets healthcare providers seeking point-of-care solutions for cardiac diagnostics, particularly in cardiology departments and clinics managing heart disease patients. Its applications cover congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The company's products are sold to hospitals and medical facilities that require advanced cardiac imaging tools. VMS+ serves as a diagnostic aid that enhances ultrasound capabilities, eliminating the need for MRI in certain scenarios. The system's ability to visualize all four heart chambers and deliver MRI-equivalent metrics positions it as a cost-effective alternative for institutions aiming to reduce MRI dependency. VentriPoint Diagnostics Ltd. focuses on commercializing these diagnostic tools for heart disease monitoring across multiple clinical segments including cardiology, obstetrics, and oncology support services. VentriPoint Diagnostics Ltd. generates revenue through the sale of its diagnostic tools, specifically the VentriPoint Medical System (VMS+), to healthcare institutions. The VMS+ system is marketed as a point-of-care solution that improves cardiac diagnostics without MRI dependency. Its applications span various heart disease contexts, including congenital conditions, pregnancy-related cardiac monitoring, pulmonary hypertension, and oncology-related cardiotoxicity. The company's commercial strategy centers on providing MRI-equivalent diagnostic capabilities through ultrasound enhancement, targeting medical facilities seeking efficient and accessible cardiac imaging solutions. VentriPoint Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VentriPoint Diagnostics stock

Gross Margin of VentriPoint Diagnostics is 100.00 % in 2025.

Gross Margin of VentriPoint Diagnostics changed from 100.00 % to 100.00 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin VentriPoint Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's VentriPoint Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — VentriPoint Diagnostics

All Key Metrics — VentriPoint Diagnostics